FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Efficacy of a cold-adapted, intranasal, equine influenza vac...
Equine veterinary journal2002; 33(7); 637-643; doi: 10.2746/042516401776249354

Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials.

Abstract: A randomised, controlled, double-blind, influenza virus, aerosol challenge of horses was undertaken to determine the efficacy of a cold-adapted, temperature sensitive, modified-live virus, intranasal, equine influenza vaccine. Ninety 11-month-old influenza-naïve foals were assigned randomly to 3 groups (20 vaccinates and 10 controls per group) and challenged 5 weeks, 6 and 12 months after a single vaccination. Challenges were performed on Day 0 in a plastic-lined chamber. Between Days 1 and 10, animals were examined daily for evidence of clinical signs of influenza. Nasal swabs for virus isolation were obtained on Day 1 and Days 1 to 8 and blood samples for serology were collected on Days 1, 7 and 14. There was no adverse response to vaccination in any animal. Following challenge at 5 weeks and 6 months, vaccinates had significantly lower clinical scores (P = 0.0001 and 0.005, respectively), experienced smaller increases in rectal temperature (P = 0.0008 and 0.0007, respectively) and shed less virus (P<0.0001 and P = 0.03, respectively) over fewer days (P<0.0001 and P = 0.002, respectively) than did the controls. After the 12 month challenge, rectal temperatures (P = 0.006) as well as the duration (P = 0.03) and concentration of virus shed (P = 0.04) were significantly reduced among vaccinated animals. The results of this study showed that 6 months after a single dose of vaccine the duration and severity of clinical signs were markedly reduced amongst vaccinated animals exposed to a severe live-virus challenge. Appropriate use of this vaccine should lead to a marked reduction in the frequency, severity and duration of outbreaks of equine influenza in North America.
Get Full Text
Publication Date: 2002-01-05 PubMed ID: 11770983DOI: 10.2746/042516401776249354Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the effectiveness of a cold-adapted, intranasal, equine influenza vaccine on horses. The results suggested that using the vaccine could drastically decrease the duration and severity of clinical signs among vaccinated animals subjected to a severe live-virus challenge.

Study Design and Experiment Procedure

  • The methodology involved a randomised, controlled, double-blind, influenza virus, aerosol challenge of horses. The objective was to determine the effectiveness of a cold-adapted, temperature-sensitive, modified-live virus, intranasal, equine influenza vaccine.
  • Ninety 11-month-old foals were randomly distributed into three groups with 20 being vaccinated, and 10 as controls, for each group. The challenge was conducted at 5 weeks, 6 and 12 months after a single vaccination.
  • In the procedure, the challenge was carried out on the first day in a plastic-lined chamber. Afterwards, between Days 1 and 10, animals underwent daily examinations for signs of flu. Nasal swabs for viral isolation were collected on Day 1 and the first eight days. Additionally, blood samples were collected for serology analysis on Days 1, 7 and 14.

Findings and Interpretation

  • There were no adverse responses to vaccination noted in any animal. Following the challenges at 5 weeks and 6 months, vaccinated horses had significantly lower clinical scores, lesser increases in rectal temperature, and shed less virus over fewer days as compared to the control groups.
  • Similar outcomes were reported after the 12-month challenge where the vaccinated animals showed significant reduction in rectal temperatures, duration, and concentration of the virus shed.
  • In summary, the study showed that six months after a single dose of the specified vaccine, the duration and severity of clinical signs were substantially reduced in vaccinated animals, after they were exposed to a severe live-virus challenge.

Study Impact

  • The findings of this research indicate the potential efficacy of this vaccine in reducing the frequency, severity, and duration of equine influenza outbreaks in North America.
  • The appropriate use of the vaccine could significantly improve the health of horses by reducing the impact of equine influenza. It also supports the potential to control and protect horse populations from influenza outbreaks.

Cite This Article

APA
Townsend HG, Penner SJ, Watts TC, Cook A, Bogdan J, Haines DM, Griffin S, Chambers T, Holland RE, Whitaker-Dowling P, Youngner JS, Sebring RW. (2002). Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet J, 33(7), 637-643. https://doi.org/10.2746/042516401776249354

Publication

Equine veterinary journal
ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 33
Issue: 7
Pages: 637-643

Researcher Affiliations

Townsend, H G
  • Department of Large Animal Clinical Sciences, University of Saskatchewan, Saskatoon, Canada.
Penner, S J
    Watts, T C
      Cook, A
        Bogdan, J
          Haines, D M
            Griffin, S
              Chambers, T
                Holland, R E
                  Whitaker-Dowling, P
                    Youngner, J S
                      Sebring, R W

                        MeSH Terms

                        • Administration, Intranasal
                        • Animals
                        • Animals, Newborn
                        • Antibodies, Viral / blood
                        • Body Temperature
                        • Cold Temperature
                        • Double-Blind Method
                        • Horse Diseases / immunology
                        • Horse Diseases / prevention & control
                        • Horses
                        • Influenza A virus / immunology
                        • Influenza A virus / isolation & purification
                        • Influenza Vaccines / administration & dosage
                        • Influenza Vaccines / immunology
                        • Influenza Vaccines / standards
                        • Nasal Mucosa / virology
                        • Orthomyxoviridae Infections / immunology
                        • Orthomyxoviridae Infections / prevention & control
                        • Orthomyxoviridae Infections / veterinary
                        • Time Factors
                        • Treatment Outcome
                        • Vaccination / veterinary
                        • Vaccines, Attenuated / immunology
                        • Vaccines, Attenuated / standards
                        • Virus Shedding

                        Citations

                        This article has been cited 18 times.
                        1. Oladunni FS, Oseni SO, Martinez-Sobrido L, Chambers TM. Equine Influenza Virus and Vaccines.. Viruses 2021 Aug 20;13(8).
                          doi: 10.3390/v13081657pubmed: 34452521google scholar: lookup
                        2. Zarski LM, Vaala WE, Barnett DC, Bain FT, Soboll Hussey G. A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.. Front Vet Sci 2021;8:674850.
                          doi: 10.3389/fvets.2021.674850pubmed: 34179166google scholar: lookup
                        3. Metcalfe L, Chevalier M, Tiberghien MP, Jolivet E, Huňady M, Timothy S, Philippe-Reversat C. Efficacy of a live intranasal vaccine against parainfluenza type 3 and bovine respiratory syncytial virus in young calves with maternally derived antibodies.. Vet Rec Open 2020;7(1):e000429.
                          doi: 10.1136/vetreco-2020-000429pubmed: 33209331google scholar: lookup
                        4. Mancera Gracia JC, Pearce DS, Masic A, Balasch M. Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies.. Front Vet Sci 2020;7:647.
                          doi: 10.3389/fvets.2020.00647pubmed: 33195504google scholar: lookup
                        5. Blanco-Lobo P, Rodriguez L, Reedy S, Oladunni FS, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus.. Viruses 2019 Oct 11;11(10).
                          doi: 10.3390/v11100933pubmed: 31614538google scholar: lookup
                        6. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies.. Front Microbiol 2018;9:1941.
                          doi: 10.3389/fmicb.2018.01941pubmed: 30237788google scholar: lookup
                        7. Rodriguez L, Reedy S, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. Development of a novel equine influenza virus live-attenuated vaccine.. Virology 2018 Mar;516:76-85.
                          doi: 10.1016/j.virol.2018.01.005pubmed: 29331866google scholar: lookup
                        8. Ozawa M, Kawaoka Y. Cross talk between animal and human influenza viruses.. Annu Rev Anim Biosci 2013 Jan;1:21-42.
                          doi: 10.1146/annurev-animal-031412-103733pubmed: 25387011google scholar: lookup
                        9. Loving CL, Vincent AL, Pena L, Perez DR. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.. Vaccine 2012 Aug 31;30(40):5830-8.
                          doi: 10.1016/j.vaccine.2012.07.033pubmed: 22835742google scholar: lookup
                        10. Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, Page AE, Donofrio-Newman J, Adams AA, Balasuriya UB, Horohov DW, Chambers TM, Nabel GJ, Rao SS. Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.. Vaccine 2012 Jun 6;30(26):3965-74.
                          doi: 10.1016/j.vaccine.2012.03.026pubmed: 22449425google scholar: lookup
                        11. Pena L, Vincent AL, Ye J, Ciacci-Zanella JR, Angel M, Lorusso A, Gauger PC, Janke BH, Loving CL, Perez DR. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.. J Virol 2011 Jan;85(1):456-69.
                          doi: 10.1128/JVI.01503-10pubmed: 20962084google scholar: lookup
                        12. Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.. Influenza Other Respir Viruses 2010 Nov;4(6):363-72.
                          doi: 10.1111/j.1750-2659.2010.00163.xpubmed: 20958930google scholar: lookup
                        13. Cullinane A, Elton D, Mumford J. Equine influenza - surveillance and control.. Influenza Other Respir Viruses 2010 Nov;4(6):339-44.
                          doi: 10.1111/j.1750-2659.2010.00176.xpubmed: 20958927google scholar: lookup
                        14. Masic A, Booth JS, Mutwiri GK, Babiuk LA, Zhou Y. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.. J Virol 2009 Oct;83(19):10198-210.
                          doi: 10.1128/JVI.00926-09pubmed: 19625412google scholar: lookup
                        15. Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.. Equine Vet J 2009 Jan;41(1):87-92.
                          doi: 10.2746/042516408x371937pubmed: 19301588google scholar: lookup
                        16. Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, García-Sastre A, Richt JA. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.. Vaccine 2007 Nov 19;25(47):7999-8009.
                          doi: 10.1016/j.vaccine.2007.09.019pubmed: 17933442google scholar: lookup
                        17. Song H, Nieto GR, Perez DR. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.. J Virol 2007 Sep;81(17):9238-48.
                          doi: 10.1128/JVI.00893-07pubmed: 17596317google scholar: lookup
                        18. Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein.. J Virol 2005 Jul;79(13):8431-9.
                          doi: 10.1128/JVI.79.13.8431-8439.2005pubmed: 15956587google scholar: lookup
                        Subscribe to our newsletter
                        Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.